These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4961263)

  • 1. Relationship between Rh-o(D) zygosity and red cell Rh-o(D) antigen content in family members.
    Masouredis SP; Dupuy ME; Elliot M
    J Clin Invest; 1967 May; 46(5):681-94. PubMed ID: 4961263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rh(D) fraction incompatibility causing hemolytic disease of the newborn. Report of two cases in a Chinese family.
    Lee SK; Tham KT; Cheung KP; Jenkins WJ
    Am J Clin Pathol; 1982 Jul; 78(1):95-6. PubMed ID: 6808826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.
    Han KS; Kim HC; Han KS; Shim WS
    Am J Perinatol; 1997 Sep; 14(8):495-7. PubMed ID: 9376014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
    Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe haemolytic disease in an infant born to an Rh(null) proposita.
    Lubenko A; Contreras M; Portugal CL; Cervi P; Forsi L; Garner SF; Pinho MO; Barbosa M; Mettrau EC; de Azevedo JG
    Vox Sang; 1992; 63(1):43-7. PubMed ID: 1413662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease of the newborn caused by anti-Rh32 and demonstration that RN encodes rhi (Ce,Rh7).
    Issitt PD; Gutgsell NS; Martin PA; Forguson JR
    Transfusion; 1991 Jan; 31(1):63-6. PubMed ID: 1898787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans.
    Barnes RM; Duguid JK; Roberts FM; Risk JM; Johnson PM; Finn R; Hardy J; Napier JA; Clarke CA
    Clin Exp Immunol; 1987 Jan; 67(1):220-6. PubMed ID: 3113783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.
    Kacem N; Chakroun T; Moussa H; Abdelkefi S; Houissa B; Chiaroni J; Jemni Yacoub S
    Transfus Med; 2012 Oct; 22(5):362-6. PubMed ID: 22757646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the LOCR (Rh55) antigen.
    Coghlan G; Moulds M; Nylen E; Zelinski T
    Transfusion; 2006 Oct; 46(10):1689-92. PubMed ID: 17002624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh proteins: key structural and functional components of the red cell membrane.
    Van Kim CL; Colin Y; Cartron JP
    Blood Rev; 2006 Mar; 20(2):93-110. PubMed ID: 15961204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho(D) genotype and red cell Rho(D) antigen content.
    MASOUREDIS SP
    Science; 1960 May; 131(3411):1442. PubMed ID: 14422083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kg, a new low-frequency red cell antigen responsible for hemolytic disease of the newborn.
    Ichikawa Y; Sato C; McCreary J; Lubenko A
    Vox Sang; 1989; 56(2):98-100. PubMed ID: 2501936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.